Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A J Mixson

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Cancer Gene Therapy|May 17, 2008
Systemic delivery of HK Raf-1 siRNA polyplexes inhibits MDA-MB-435 xenograftsQ Leng, P Scaria, P Lu, et al.
Cancer Gene Therapy|August 6, 2011
Selective modification of HK peptides enhances siRNA silencing of tumor targets in vivoS-T Chou, Q Leng, P Scaria, et al.
Molecular Genetics and Metabolism|August 28, 1998
In vivo gene therapy with a cationic polymer markedly enhances the antitumor activity of antiangiogenic genesM Xu, Q R Chen, D Kumar, et al.
Clinical Endocrinology|March 1, 1993
Identification of a novel mutation in the gene encoding the beta-triiodothyronine receptor in a patient with apparent selective pituitary resistance to thyroid hormoneA J Mixson, J C Renault, S Ransom, et al.
The Journal of Clinical Investigation|December 1, 1991
Characterization of seven novel mutations of the c-erbA beta gene in unrelated kindreds with generalized thyroid hormone resistance. Evidence for two "hot spot" regions of the ligand binding domainR Parrilla, A J Mixson, J A McPherson, et al.
Biochemical and Biophysical Research Communications|December 15, 1992
The proto-oncogenes c-fos and c-jun modulate thyroid hormone inhibition of human thyrotropin beta subunit gene expression in opposite directionsD L Bodenner, J H McClaskey, M K Kim, et al.
Human Gene Therapy|April 1, 1995
Systemic gene therapy with p53 reduces growth and metastases of a malignant human breast cancer in nude miceL A Lesoon-Wood, W H Kim, H K Kleinman, et al.
The Journal of Clinical Investigation|May 1, 1993
Differential expression of mutant and normal beta T3 receptor alleles in kindreds with generalized resistance to thyroid hormoneA J Mixson, P Hauser, G Tennyson, et al.
Biochemistry|April 12, 1994
Analysis of the binding of 3,3',5-triiodo-L-thyronine and its analogues to mutant human beta 1 thyroid hormone receptors: a model of the hormone binding siteS Y Cheng, S C Ransom, P McPhie, et al.
The New England Journal of Medicine|April 8, 1993
Attention deficit-hyperactivity disorder in people with generalized resistance to thyroid hormoneP Hauser, A J Zametkin, P Martinez, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Cancer Gene Therapy|May 17, 2008
Systemic delivery of HK Raf-1 siRNA polyplexes inhibits MDA-MB-435 xenograftsQ Leng, P Scaria, P Lu, et al.
Cancer Gene Therapy|August 6, 2011
Selective modification of HK peptides enhances siRNA silencing of tumor targets in vivoS-T Chou, Q Leng, P Scaria, et al.
Molecular Genetics and Metabolism|August 28, 1998
In vivo gene therapy with a cationic polymer markedly enhances the antitumor activity of antiangiogenic genesM Xu, Q R Chen, D Kumar, et al.
Clinical Endocrinology|March 1, 1993
Identification of a novel mutation in the gene encoding the beta-triiodothyronine receptor in a patient with apparent selective pituitary resistance to thyroid hormoneA J Mixson, J C Renault, S Ransom, et al.
The Journal of Clinical Investigation|December 1, 1991
Characterization of seven novel mutations of the c-erbA beta gene in unrelated kindreds with generalized thyroid hormone resistance. Evidence for two "hot spot" regions of the ligand binding domainR Parrilla, A J Mixson, J A McPherson, et al.
Biochemical and Biophysical Research Communications|December 15, 1992
The proto-oncogenes c-fos and c-jun modulate thyroid hormone inhibition of human thyrotropin beta subunit gene expression in opposite directionsD L Bodenner, J H McClaskey, M K Kim, et al.
Human Gene Therapy|April 1, 1995
Systemic gene therapy with p53 reduces growth and metastases of a malignant human breast cancer in nude miceL A Lesoon-Wood, W H Kim, H K Kleinman, et al.
The Journal of Clinical Investigation|May 1, 1993
Differential expression of mutant and normal beta T3 receptor alleles in kindreds with generalized resistance to thyroid hormoneA J Mixson, P Hauser, G Tennyson, et al.
Biochemistry|April 12, 1994
Analysis of the binding of 3,3',5-triiodo-L-thyronine and its analogues to mutant human beta 1 thyroid hormone receptors: a model of the hormone binding siteS Y Cheng, S C Ransom, P McPhie, et al.
The New England Journal of Medicine|April 8, 1993
Attention deficit-hyperactivity disorder in people with generalized resistance to thyroid hormoneP Hauser, A J Zametkin, P Martinez, et al.
Pageof 3